蟾雄膏外敷治疗血瘀热毒型胃癌癌痛的临床效果

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (748 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract

[Abstract] Objective To observe the effect of external application of Chanxiong Plaster on gastric cancer pain with syndrome of blood stasis and heat toxin. Methods A total of 72 patients with gastric cancer pain with syndrome of blood stasis and heat toxin treated in Xishan Traditional Chinese Medicine Hospital of Wuxi, Jiangsu Province from January 2019 to July 2021 were selected as the research subjects, according to random number table method, they were divided into observation group and control group, with 36 cases in each group. The control group was treated with three-step standard treatment, and the observation group was treated with external application of Chanxiong Plaster. After one week, the clinical efficacy, pain relief onset time, pain relief duration time, burst pain times, traditional Chinese medicine syndrome score were compared. Serum 5-hydroxytryptamine (5-HT) and β-endorphin (β-EP) levels were detected before and after treatment, and the safety was evaluated. Results In the observation group, 34 cases were observed and two cases were fell off. In the control group, 33 cases were observed and three cases were fell off. The clinical efficacy of the observation group was better than that of the control group, the difference was statistically significant (P ＜ 0.05). After treatment, the onset time of pain relief and the outbreak times of pain in the observation group were shorter than those in the control group (P ＜ 0.05); the duration time of pain relief in the observation group was longer than that in the control group, the difference was statistically significant (P ＜ 0.05). After treatment, and the scores of traditional Chinese medicine syndrome in the observation group were lower than those in the control group, the differences were statistically significant (P ＜ 0.05). After treatment, the serum 5-HT contents in both groups were lower than those before treatment, and that in the observation group was lower than that in the control group, while the β-EP contents in both groups were increased, and that in the observation group was higher than that in the control group, the difference was statistically significant (P ＜ 0.05). In this study, two patients in observation group showed symptoms of pruritus and mild edema at the application site after treatment, which disappeared after external application of Qingdai Powder. No obvious adverse events were observed in control group. Conclusion External application of Chanxiong Plaster can effectively treat gastric cancer pain with syndrome of blood stasis and heat toxin without obvious adverse reactions, and it is worthy of clinical promotion.

Key words： Chanxiong Plaster Gastric cancer Cancer pain Blood stasis and heat toxin

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	XU Zhangying1 HUANG Lingying2 GAO Yueqiu2 XUE Yuzheng3▲

Cite this article:

XU Zhangying1 HUANG Lingying2 GAO Yueqiu2 XUE Yuzheng3▲. Clinical effect of external application of Chanxiong Plaster on gastric cancer pain with syndrome of blood stasis and heat toxin[J]. 中国医药导报, 2022, 19(18): 119-122,127.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I18/119

[1] 刘宗超，李哲轩，张阳，等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志，2021，7（2）：1-14.
[2] 王李坛，翁少文，王余娜，等.微信延续性营养干预对院外胃癌术后患者希望水平、生活质量及营养状态的影响[J].中国医药导报，2021，18（34）：185-188.
[3] 王曼，刘传波，卫月，等.中医外治法在癌痛治疗中的应用及思考[J].中华中医药杂志，2020，35（12）：6244-6247.
[4] 张娟，杨兴勇，任吉伟.自拟癌痛散外用对骨转移性癌痛缓解及患者治疗依从性的影响[J].四川中医，2021，39（1）：205-208.
[5] 王庆才，陈爱平，李苏，等.蟾雄膏外敷治疗癌性疼痛103例[J].陕西中医，1993，14（5）：195.
[6] 中国临床肿瘤学会指南工作委员会.《中国临床肿瘤学会（CSCO）胃癌诊疗指南2020》[M].北京：人民卫生出版社，2020，1（1）：15-27.
[7] 沈波，杨扬，申文，等.江苏省成人癌症疼痛诊疗规范（2020年版）[J].中国肿瘤临床，2020，47（7）：1-18，325-333.
[8] 郑筱萸.中药新药临床研究指导原则[M].北京：中国医药科技出版社，2002.
[9] Shkodra M，Brunelli C，Zecca E，et al. Neuropathic pain：clinical classification and assessment in patients with pain due to cancer [J]. Pain，2021，162（3）：866-874.
[10] 郑华，王昆，张咸伟.《癌性爆发痛专家共识》（2019年版）解读[J].医药导报，2021，40（1）：20-23.
[11] 贾立群，娄彦妮.癌性疼痛中医外治诊疗规范专家共识意见[J].北京中医药，2014，（4）：305-307.
[12] 王稳，樊碧发.癌痛发生机制的研究进展[J].中国疼痛医学杂志，2021，27（8）：616-618.
[13] 宋颖，田畅，冯莉霞.护理人员对癌性爆发痛认知及管理现状的调查研究[J].上海护理，2021，21（9）：18-21.
[14] 陈丽琼，何宝英，黄秋玲.中晚期癌症患者癌性爆发痛影响因素分析及疼痛规范化管理对策[J].齐鲁护理杂志，2021，27（11）：141-143.
[15] 程海波，吴勉华．周仲瑛教授“癌毒”学术思想探析[J].中华中医药杂志，2020，25（6）：866-869.
[16] 朱晓丹，袁可淼，陈喆，等.消癥止痛膏外用治疗癌性腹部胀痛的临床研究[J].现代中西医结合杂志，2021，30（15）：1611-1615，1621.
[17] 巴茜远，周诗旸，罗欣欣，等.华蟾素抗癌性疼痛的药理作用及作用机制的研究进展[J].中国疼痛医学杂志，2019，25（9）：4.
[18] 周晴晴，李慧杰，李秀荣.基于癌毒理论探讨攻毒治法抗肿瘤血管生成[J].陕西中医，2020，41（8）：5.
[19] 齐娜，段文娟，李雅婧，等.麝香酮药理作用的研究进展[J].世界科学技术-中医药现代化，2020，22（8）：3042-3047.
[20] 杜可心，李冬云，董佳，等.乳香-没药治疗癌性疼痛的网络药理学研究[J].世界中西医结合杂志，2020，15（9）：6.
[21] 石娜娜，何若琳，陈旭义，等.大黄素抗肿瘤作用机制的研究进展[J].环球中医药，2019，12（4）：4.
[22] 侯克刚，茅菲，何姣燕，等.大黄芒硝外敷治疗宫颈癌术后盆腔淋巴囊肿的临床研究[J].中华中医药学刊，2020， 38（6）：109-111.
[23] 徐坤元，王佳，周毅德.干蟾皮、硇砂、三七治疗胃癌经验——仝小林三味小方撷萃[J].吉林中医药，2020，40（8）：986-988.
[24] 穆强，王林.中枢5-HT系统与疼痛的相关性研究进展[J].现代医药卫生，2020，36（19）：3117-3121.
[25] Chong D，Shao L，Yang Y，et al. Correlations of cancer pain degree with levels of β-EP，CGRP and PGE2 and the effects of oxycontin on them [J]. J BUON，2018，23（5）：1552-1557.